Skip to main content

Animations

MJFF Publications

2761 - 2770 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2025
  • 2024
  • 2025
  • 2021
  • 2022
  • 2025
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Smaller Total and Subregional Cerebellar Volumes in Posttraumatic Stress Disorder: A Mega-Analysis by the ENIGMA-PGC PTSD Workgroup
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2023.02.123
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Impact of Y chromosome loss on the risk of Parkinson's disease and progression
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105769
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
    Journal Name: Immunobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.imbio.2025.152892
    Citation Count: 0
  • Summary Details
    OPEN
    Title: α-Synuclein aggregation decreases cortico-amygdala connectivity and impairs social behavior in mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2024.106702
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Protocol to identify regulatory modules in Parkinson’s disease progression using miRNA data and Boolean modeling
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2025.103769
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Large‐scale deep multi‐layer analysis of Alzheimer’s disease brain reveals strong proteomic disease‐related changes not observed at the RNA level
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.055041
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/alz.060159
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Parkinson’s Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype? (S32.005)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000212426
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Identifying prodromal symptoms at high specificity for Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1232387
    Citation Count: 5
  • Summary Details
    OPEN
    Title: How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad265
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.